This is bolstered by the observation that FOXM1 induces resistance to radiotherapy by modulating the activity of SOX-2 [44]; also the TFs FANCD2 and E2F8 have expression levels strongly associated with GBM malignancy progression [46], as has TFDP1 [48]. Here, FANCD2 is linked to glioblastoma.